Vitura Health Ltd
F:1CE0
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Vitura Health Ltd
F:1CE0
|
AU |
|
TechnipFMC PLC
NYSE:FTI
|
UK |
|
K
|
Kone Oyj
XMUN:KC4
|
FI |
|
S
|
SoftBank Corp
OTC:SOBKY
|
JP |
|
L
|
Larimar Therapeutics Inc
F:ZA71
|
US |
|
A
|
AES Corp
XMUN:AES
|
US |
|
Neuropace Inc
NASDAQ:NPCE
|
US |
|
G
|
Givaudan SA
DUS:GIN
|
CH |
|
E
|
Endesa SA
XMUN:ENA
|
ES |
|
C
|
Carlisle Companies Inc
F:CLE
|
US |
|
Alset AI Ventures Inc
OTC:GPUSD
|
CA |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 1CE0's stock price target?
Not Available
1CE0 does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Vitura Health Ltd?
Projected CAGR
81%
The compound annual growth rate for Revenue over the next 1 year is 81%.
What is the Gross Profit forecast for Vitura Health Ltd?
Projected CAGR
12%
The compound annual growth rate for Gross Profit over the next 2 years is 12%.
What is the Operating Income forecast for Vitura Health Ltd?
Projected CAGR
590%
The compound annual growth rate for Operating Income over the next 1 year is 590%.
What is the Pre-Tax Income forecast for Vitura Health Ltd?
Projected CAGR
123%
The compound annual growth rate for Pre-Tax Income over the next 2 years is 123%.
What is the Net Income forecast for Vitura Health Ltd?
Projected CAGR
122%
The compound annual growth rate for Net Income over the next 2 years is 122%.
